Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2025 ,inter alia, to consider and approve unaudited financial ....
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Solara Active Pharma Sciences has informed BSE and NSE that its Board of Directors will meet on November 5, 2025, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. The trading window for designated persons has been closed from October 1, 2025, until 48 hours after the results are announced, as per insider trading regulations. The filing is a standard procedural intimation under SEBI Listing Regulations and contains no financial details yet.
This is a routine pre-results announcement and typically has no immediate impact on the stock price. Investors should watch for the actual Q2/H1 FY26 numbers when announced on or after November 5, 2025, for any meaningful signal on the company's performance.